Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 20/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17429290 | 0.89 | HTR6 (1.00) | HTR6 | |
| SCHEMBL17429202 | 0.89 | HTR6 (1.00) | HTR6 | |
| SCHEMBL17422092 | 0.88 | HTR6 (1.00) | HTR6 | |
| SCHEMBL17422110 | 0.88 | HTR6 (1.00) | HTR6 | |
| SCHEMBL17429368 | 0.88 | HTR6 (1.00) | HTR6 | |
| SCHEMBL17429296 | 0.86 | HTR6 (1.00) | HTR6 | |
| SCHEMBL17429206 | 0.86 | HTR6 (0.79) | HTR6 | |
| SCHEMBL17429204 | 0.86 | HTR6 (1.00) | HTR6 | |
| SCHEMBL17429207 | 0.86 | HTR6 (0.75) | HTR6 | |
| SCHEMBL17429199 | 0.85 | HTR6 (1.00) | HTR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111233736-B | Salts of heteroaromatic derivatives and use thereof | 东莞市东阳光新药研发有限公司 | 2021-07-16 | — | — | CN | disclosed |
| CN-111362859-B | Salts of heteroaromatic derivatives and use thereof | 东莞市东阳光新药研发有限公司 | 2021-05-11 | — | — | CN | disclosed |
| CN-111362858-B | Salts of heteroaromatic derivatives and use thereof | 东莞市东阳光新药研发有限公司 | 2021-05-11 | — | — | CN | disclosed |
| CN-111233737-B | Salts of heteroaromatic derivatives and use thereof | 东莞市东阳光新药研发有限公司 | 2021-05-11 | — | — | CN | disclosed |
| CN-111362858-A | Salts of heteroaromatic derivatives and use thereof | 东莞市东阳光新药研发有限公司 | 2020-07-03 | — | — | CN | disclosed |
| CN-111362859-A | Salts of heteroaromatic derivatives and use thereof | 东莞市东阳光新药研发有限公司 | 2020-07-03 | — | — | CN | disclosed |
| CN-111302998-A | Salts of heteroaromatic derivatives and use thereof | 东莞市东阳光新药研发有限公司 | 2020-06-19 | — | — | CN | disclosed |
| CN-111233738-A | Fumarate of aromatic heterocyclic derivative and application thereof | 东莞市东阳光新药研发有限公司 | 2020-06-05 | — | — | CN | disclosed |
| CN-111233736-A | Salts of heteroaromatic derivatives and use thereof | 东莞市东阳光新药研发有限公司 | 2020-06-05 | — | — | CN | disclosed |
| CN-111233737-A | Salts of heteroaromatic derivatives and use thereof | 东莞市东阳光新药研发有限公司 | 2020-06-05 | — | — | CN | disclosed |
| EP-3166924-B1 | AROMATIC HETEROCYCLIC DERIVATIVES AND PHARMACEUTICAL APPLICATIONS THEREOF | SUNSHINE LAKE PHARMA CO LTD (CN) | 2019-02-20 | — | — | EP | disclosed |
| EP-3166924-B1 | AROMATIC HETEROCYCLIC DERIVATIVES AND PHARMACEUTICAL APPLICATIONS THEREOF | SUNSHINE LAKE PHARMA CO LTD (CN) | 2019-02-20 | — | — | EP | disclosed |
| US-9974785-B2 | Aromatic heterocyclic derivatives and pharmaceutical applications thereof | SUNSHINE LAKE PHARMA CO., LTD. (CN) | 2018-05-22 | — | — | US | disclosed |
| US-9974785-B2 | Aromatic heterocyclic derivatives and pharmaceutical applications thereof | SUNSHINE LAKE PHARMA CO., LTD. (CN) | 2018-05-22 | — | — | US | disclosed |
| US-20170096392-A1 | AROMATIC HETEROCYCLIC DERIVATIVES AND PHARMACEUTICAL APPLICATIONS THEREOF | SUNSHINE LAKE PHARMA CO., LTD. (CN) | 2017-04-06 | — | — | US | disclosed |
| US-20170096392-A1 | AROMATIC HETEROCYCLIC DERIVATIVES AND PHARMACEUTICAL APPLICATIONS THEREOF | SUNSHINE LAKE PHARMA CO., LTD. (CN) | 2017-04-06 | — | — | US | disclosed |
| WO-2016004882-A1 | AROMATIC HETEROCYCLIC DERIVATIVES AND PHARMACEUTICAL APPLICATIONS THEREOF | SUNSHINE LAKE PHARMA CO., LTD. (CN) | 2016-01-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170096392-A1 | AROMATIC HETEROCYCLIC DERIVATIVES AND PHARMACEUTICAL APPLICATIONS THEREOF | HTR6, HTR3A, HTR5A | HTR6 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.